Loading
Life sciences · Journal article
Acs Omega · October 13, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Skin cancer therapy still presents limitations regarding efficacy and invasiveness, which highlights the need for alternative therapeutic approaches. Quercetin has emerged as a promising natural compound because of its antioxidant, anti-inflammatory, and potential antitumor effects. However, its clinical topical application is limited by low bioavailability. The use of thermoresponsive and bioadhesive polymeric systems constitutes a promising strategy for topical administration. This study aimed to investigate formulations composed of poloxamer 407 and cellulose derivatives containing quercetin for the treatment of skin cancers. Therefore, the systems were evaluated regarding in vitro quercetin release profile, ex vivo skin permeation, micelle morphology, formulation toxicity using Artemia salina, cytotoxicity, and effects on cell proliferation using fibroblasts and melanoma cells. The formulations showed prolonged release, promoting controlled quercetin release over time, and the ability to permeate deeper skin layers. The hydrodynamic diameter was within the nanometric scale, and the systems exhibited a homogeneous micellar distribution. None of the formulations were cytotoxic or cytostatic in both fibroblasts and melanoma cell lines. The F2-Q4 altered cellular metabolic activity in melanoma cells, suggesting a modulation of cellular metabolism. Interestingly, this effect was not observed in nontumoral fibroblasts. Further studies are required to elucidate the mechanisms involved and investigate the potential of this system for topical melanoma treatment.